Skip to content

Clinical trials

Phase 1 Sjogren's Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sjogren's Syndrome Phase: Phase 1 Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20211
20231
20243
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Not yet recruiting4
Suspended2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanjing Bioheng Biotech Co., Ltd.3
China Immunotech (Beijing) Biotechnology Co., Ltd.2
Antengene Biologics Limited1
Beijing Boren Hospital1
Children's Hospital of Fudan University1
Chongqing Precision Biotech Co., Ltd1
First Affiliated Hospital of Wenzhou Medical University1
Peking University Third Hospital1
RenJi Hospital1
Shanghai Changzheng Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sjogren's Syndrome15
Lupus Erythematosus, Systemic13
Scleroderma, Systemic12
Myositis11
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis10
Antiphospholipid Syndrome5
Autoimmune Diseases5
Anemia, Hemolytic, Autoimmune1
Arthritis, Rheumatoid1
Dermatomyositis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.